 | • レポートコード：QY20ST-08090 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の乳がん治療薬市場について種類別（HER2阻害剤、有糸分裂阻害剤、代謝拮抗剤、アロマターゼ阻害剤）、用途別（ Hospitals Clinics Others ）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・乳がん治療薬市場の概要 ・世界の主要地域別乳がん治療薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の乳がん治療薬市場規模2015-2026：種類別（HER2阻害剤、有糸分裂阻害剤、代謝拮抗剤、アロマターゼ阻害剤） ・世界の乳がん治療薬市場規模2015-2026：用途別（ Hospitals Clinics Others ） ・乳がん治療薬の北米市場規模2015-2020 ・乳がん治療薬のヨーロッパ市場規模2015-2020 ・乳がん治療薬の中国市場規模2015-2020 ・乳がん治療薬の日本市場規模2015-2020 ・乳がん治療薬の東南アジア市場規模2015-2020 ・乳がん治療薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・乳がん治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・乳がん治療薬の市場動向・機会・課題 ・調査の結論 |
Breast Cancer Drugs are a type of drugs developed to cure or prevent breast cancer.
Market Analysis and Insights: Global Breast Cancer Drugs Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Breast Cancer Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Breast Cancer Drugs industry.
Based on our recent survey, we have several different scenarios about the Breast Cancer Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 14560 million in 2019. The market size of Breast Cancer Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Breast Cancer Drugs Scope and Market Size
The global Breast Cancer Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Breast Cancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Breast Cancer Drugs market is segmented into
HER2 Inhibitors
Mitotic Inhibitors
Anti-Metabolites
Aromatase Inhibitors
Segment by Application, the Breast Cancer Drugs market is segmented into
Hospitals
Clinics
Others
The Breast Cancer Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Breast Cancer Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Breast Cancer Drugs Market Share Analysis
Breast Cancer Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Breast Cancer Drugs business, the date to enter into the Breast Cancer Drugs market, Breast Cancer Drugs product introduction, recent developments, etc.
The major vendors covered:
Roche Group
Novartis
Pfizer
Bristol-Myers Squibb
Puma Biotech
Verzenio (Eli Lilly)
HALAVEN (Eisai Inc)
AstraZeneca
GlaxoSmithKline
Merck Sharp & Dohme Corp.
Dr Reddy’s Laboratories
Celltrion Inc
Biocon
Mylan
1 Breast Cancer Drugs Market Overview
1.1 Breast Cancer Drugs Product Scope
1.2 Breast Cancer Drugs Segment by Type
1.2.1 Global Breast Cancer Drugs Sales by Type (2020-2026)
1.2.2 HER2 Inhibitors
1.2.3 Mitotic Inhibitors
1.2.4 Anti-Metabolites
1.2.5 Aromatase Inhibitors
1.3 Breast Cancer Drugs Segment by Application
1.3.1 Global Breast Cancer Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Breast Cancer Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Breast Cancer Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Breast Cancer Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Breast Cancer Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Breast Cancer Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Breast Cancer Drugs Industry
1.5.1.1 Breast Cancer Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Breast Cancer Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Breast Cancer Drugs Players to Combat Covid-19 Impact
2 Breast Cancer Drugs Estimate and Forecast by Region
2.1 Global Breast Cancer Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Breast Cancer Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Breast Cancer Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Breast Cancer Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Breast Cancer Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Breast Cancer Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Breast Cancer Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Breast Cancer Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Breast Cancer Drugs Estimates and Projections (2015-2026)
2.4.3 China Breast Cancer Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Breast Cancer Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Breast Cancer Drugs Estimates and Projections (2015-2026)
2.4.6 India Breast Cancer Drugs Estimates and Projections (2015-2026)
3 Global Breast Cancer Drugs Competition Landscape by Players
3.1 Global Top Breast Cancer Drugs Players by Sales (2015-2020)
3.2 Global Top Breast Cancer Drugs Players by Revenue (2015-2020)
3.3 Global Breast Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Drugs as of 2019)
3.4 Global Breast Cancer Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Breast Cancer Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Breast Cancer Drugs Players (Opinion Leaders)
4 Global Breast Cancer Drugs Market Size by Type
4.1 Global Breast Cancer Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Breast Cancer Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Breast Cancer Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Breast Cancer Drugs Price by Type (2014-2020)
4.2 Global Breast Cancer Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Breast Cancer Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Breast Cancer Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Breast Cancer Drugs Price Forecast by Type (2021-2026)
5 Global Breast Cancer Drugs Market Size by Application
5.1 Global Breast Cancer Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Breast Cancer Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Breast Cancer Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Breast Cancer Drugs Price by Application (2015-2020)
5.2 Global Breast Cancer Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Breast Cancer Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Breast Cancer Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Breast Cancer Drugs Price Forecast by Application (2021-2026)
3 North America Breast Cancer Drugs Market Facts & Figures
3.2 North America Breast Cancer Drugs Sales Market Share by Company (2015-2020)
3.3 North America Breast Cancer Drugs Sales Market Share by Type (2015-2020)
3.4 North America Breast Cancer Drugs Sales Market Share by Application (2015-2020)
4 Europe Breast Cancer Drugs Market Facts & Figures
4.2 Europe Breast Cancer Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Breast Cancer Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Breast Cancer Drugs Sales Market Share by Application (2015-2020)
5 China Breast Cancer Drugs Market Facts & Figures
5.2 China Breast Cancer Drugs Sales Market Share by Company (2015-2020)
5.3 China Breast Cancer Drugs Sales Market Share by Type (2015-2020)
5.4 China Breast Cancer Drugs Sales Market Share by Application (2015-2020)
6 Japan Breast Cancer Drugs Market Facts & Figures
6.2 Japan Breast Cancer Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Breast Cancer Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Breast Cancer Drugs Sales Market Share by Application (2015-2020)
7 Southeast Asia Breast Cancer Drugs Market Facts & Figures
7.2 Southeast Asia Breast Cancer Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Breast Cancer Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Breast Cancer Drugs Sales Market Share by Application (2015-2020)
8 India Breast Cancer Drugs Market Facts & Figures
8.2 India Breast Cancer Drugs Sales Market Share by Company (2015-2020)
8.3 India Breast Cancer Drugs Sales Market Share by Type (2015-2020)
8.4 India Breast Cancer Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Breast Cancer Drugs Business
12.1 Roche Group
12.1.1 Roche Group Breast Cancer Drugs Corporation Information
12.1.2 Roche Group Breast Cancer Drugs Business Overview and Total Revenue
12.1.3 Roche Group Breast Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Roche Group Breast Cancer Drugs Products Offered
12.1.5 Roche Group Recent Development
12.2 Novartis
12.2.1 Novartis Breast Cancer Drugs Corporation Information
12.2.2 Novartis Breast Cancer Drugs Business Overview and Total Revenue
12.2.3 Novartis Breast Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis Breast Cancer Drugs Products Offered
12.2.5 Novartis Recent Development
12.3 Pfizer
12.3.1 Pfizer Breast Cancer Drugs Corporation Information
12.3.2 Pfizer Breast Cancer Drugs Business Overview and Total Revenue
12.3.3 Pfizer Breast Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Pfizer Breast Cancer Drugs Products Offered
12.3.5 Pfizer Recent Development
12.4 Bristol-Myers Squibb
12.4.1 Bristol-Myers Squibb Breast Cancer Drugs Corporation Information
12.4.2 Bristol-Myers Squibb Breast Cancer Drugs Business Overview and Total Revenue
12.4.3 Bristol-Myers Squibb Breast Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Bristol-Myers Squibb Breast Cancer Drugs Products Offered
12.4.5 Bristol-Myers Squibb Recent Development
12.5 Puma Biotech
12.5.1 Puma Biotech Breast Cancer Drugs Corporation Information
12.5.2 Puma Biotech Breast Cancer Drugs Business Overview and Total Revenue
12.5.3 Puma Biotech Breast Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Puma Biotech Breast Cancer Drugs Products Offered
12.5.5 Puma Biotech Recent Development
12.6 Verzenio (Eli Lilly)
12.6.1 Verzenio (Eli Lilly) Breast Cancer Drugs Corporation Information
12.6.2 Verzenio (Eli Lilly) Breast Cancer Drugs Business Overview and Total Revenue
12.6.3 Verzenio (Eli Lilly) Breast Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Verzenio (Eli Lilly) Breast Cancer Drugs Products Offered
12.6.5 Verzenio (Eli Lilly) Recent Development
12.7 HALAVEN (Eisai Inc)
12.7.1 HALAVEN (Eisai Inc) Breast Cancer Drugs Corporation Information
12.7.2 HALAVEN (Eisai Inc) Breast Cancer Drugs Business Overview and Total Revenue
12.7.3 HALAVEN (Eisai Inc) Breast Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 HALAVEN (Eisai Inc) Breast Cancer Drugs Products Offered
12.7.5 HALAVEN (Eisai Inc) Recent Development
12.8 AstraZeneca
12.8.1 AstraZeneca Breast Cancer Drugs Corporation Information
12.8.2 AstraZeneca Breast Cancer Drugs Business Overview and Total Revenue
12.8.3 AstraZeneca Breast Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 AstraZeneca Breast Cancer Drugs Products Offered
12.8.5 AstraZeneca Recent Development
12.9 GlaxoSmithKline
12.9.1 GlaxoSmithKline Breast Cancer Drugs Corporation Information
12.9.2 GlaxoSmithKline Breast Cancer Drugs Business Overview and Total Revenue
12.9.3 GlaxoSmithKline Breast Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 GlaxoSmithKline Breast Cancer Drugs Products Offered
12.9.5 GlaxoSmithKline Recent Development
12.10 Merck Sharp & Dohme Corp.
12.10.1 Merck Sharp & Dohme Corp. Breast Cancer Drugs Corporation Information
12.10.2 Merck Sharp & Dohme Corp. Breast Cancer Drugs Business Overview and Total Revenue
12.10.3 Merck Sharp & Dohme Corp. Breast Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Merck Sharp & Dohme Corp. Breast Cancer Drugs Products Offered
12.10.5 Merck Sharp & Dohme Corp. Recent Development
12.11 Dr Reddy’s Laboratories
12.11.1 Dr Reddy’s Laboratories Breast Cancer Drugs Corporation Information
12.11.2 Dr Reddy’s Laboratories Breast Cancer Drugs Business Overview and Total Revenue
12.11.3 Dr Reddy’s Laboratories Breast Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Dr Reddy’s Laboratories Breast Cancer Drugs Products Offered
12.11.5 Dr Reddy’s Laboratories Recent Development
12.12 Celltrion Inc
12.12.1 Celltrion Inc Breast Cancer Drugs Corporation Information
12.12.2 Celltrion Inc Breast Cancer Drugs Business Overview and Total Revenue
12.12.3 Celltrion Inc Breast Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Celltrion Inc Breast Cancer Drugs Products Offered
12.12.5 Celltrion Inc Recent Development
12.13 Biocon
12.13.1 Biocon Breast Cancer Drugs Corporation Information
12.13.2 Biocon Breast Cancer Drugs Business Overview and Total Revenue
12.13.3 Biocon Breast Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Biocon Breast Cancer Drugs Products Offered
12.13.5 Biocon Recent Development
12.14 Mylan
12.14.1 Mylan Breast Cancer Drugs Corporation Information
12.14.2 Mylan Breast Cancer Drugs Business Overview and Total Revenue
12.14.3 Mylan Breast Cancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Mylan Breast Cancer Drugs Products Offered
12.14.5 Mylan Recent Development
13 Breast Cancer Drugs Manufacturing Cost Analysis
13.1 Breast Cancer Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Breast Cancer Drugs
13.4 Breast Cancer Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Breast Cancer Drugs Distributors List
14.3 Breast Cancer Drugs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Breast Cancer Drugs Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Breast Cancer Drugs Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Breast Cancer Drugs Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Breast Cancer Drugs Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Breast Cancer Drugs Players to Combat Covid-19 Impact
Table 8. Global Market Breast Cancer Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Breast Cancer Drugs Sales (K Units) by Region (2015-2020)
Table 10. Global Breast Cancer Drugs Sales Market Share by Region (2015-2020)
Table 11. Global Breast Cancer Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Breast Cancer Drugs Revenue Share by Region (2015-2020)
Table 13. Global Breast Cancer Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Breast Cancer Drugs Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Breast Cancer Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Breast Cancer Drugs Revenue Share Forecast by Region (2021-2026)
Table 17. Global Breast Cancer Drugs (K Units) of Key Companies (2015-2020)
Table 18. Global Breast Cancer Drugs Sales Share by Company (2015-2020)
Table 19. Global Breast Cancer Drugs Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Breast Cancer Drugs Revenue Share by Company (2015-2020)
Table 21. Global Breast Cancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Drugs as of 2019)
Table 22. Global Breast Cancer Drugs Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Breast Cancer Drugs Manufacturing Sites and Area Served
Table 24. Manufacturers Breast Cancer Drugs Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Breast Cancer Drugs Players
Table 27. Global Breast Cancer Drugs Sales (K Units) by Type (2015-2020)
Table 28. Global Breast Cancer Drugs Sales Share by Type (2015-2020)
Table 29. Global Breast Cancer Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Breast Cancer Drugs Price (K Units) by Type (2015-2020)
Table 31. Global Breast Cancer Drugs Sales Share by Type (2021-2026)
Table 32. Global Breast Cancer Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Breast Cancer Drugs Revenue Share by Type (2021-2026)
Table 34. Global Breast Cancer Drugs Price (K Units) by Type (2021-2026)
Table 35. Global Breast Cancer Drugs Sales (K Units) by Application (2015-2020)
Table 36. Global Breast Cancer Drugs Sales Share by Application (2015-2020)
Table 37. Global Breast Cancer Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Breast Cancer Drugs Price (K Units) by Application (2015-2020)
Table 39. Global Breast Cancer Drugs Sales (K Units) by Application (2021-2026)
Table 40. Global Breast Cancer Drugs Sales Share by Application (2021-2026)
Table 41. Global Breast Cancer Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Breast Cancer Drugs Revenue Share by Application (2021-2026)
Table 43. Global Breast Cancer Drugs Price (K Units) by Application (2021-2026)
Table 44. United States Breast Cancer Drugs Sales (K Units) by Company (2015-2020)
Table 45. United States Breast Cancer Drugs Sales Market Share by Company (2015-2020)
Table 46. United States Breast Cancer Drugs Sales (K Units) by Type (2015-2020)
Table 47. United States Breast Cancer Drugs Sales Market Share by Type (2015-2020)
Table 48. United States Breast Cancer Drugs Sales (K Units) by Application (2015-2020)
Table 49. United States Breast Cancer Drugs Sales Market Share by Application (2015-2020)
Table 50. Europe Breast Cancer Drugs Sales (K Units) by Company (2015-2020)
Table 51. Europe Breast Cancer Drugs Sales Market Share by Company (2015-2020)
Table 52. Europe Breast Cancer Drugs Sales (K Units) by Type (2015-2020)
Table 53. Europe Breast Cancer Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe Breast Cancer Drugs Sales (K Units) by Application (2015-2020)
Table 55. Europe Breast Cancer Drugs Sales Market Share by Type (2015-2020)
Table 56. China Breast Cancer Drugs Sales (K Units) by Company (2015-2020)
Table 57. China Breast Cancer Drugs Sales Market Share by Company (2015-2020)
Table 58. China Breast Cancer Drugs Sales (K Units) by Type (2015-2020)
Table 59. China Breast Cancer Drugs Sales Market Share by Type (2015-2020)
Table 60. China Breast Cancer Drugs Sales (K Units) by Application (2015-2020)
Table 61. China Breast Cancer Drugs Sales Market Share by Application (2015-2020)
Table 62. Japan Breast Cancer Drugs Sales (K Units) by Company (2015-2020)
Table 63. Japan Breast Cancer Drugs Sales Market Share by Company (2015-2020)
Table 64. Japan Breast Cancer Drugs Sales (K Units) by Type (2015-2020)
Table 65. Japan Breast Cancer Drugs Sales Market Share by Type (2015-2020)
Table 66. Japan Breast Cancer Drugs Sales (K Units) by Application (2015-2020)
Table 67. Japan Breast Cancer Drugs Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Breast Cancer Drugs Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Breast Cancer Drugs Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Breast Cancer Drugs Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Breast Cancer Drugs Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Breast Cancer Drugs Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Breast Cancer Drugs Sales Market Share by Application (2015-2020)
Table 74. India Breast Cancer Drugs Sales (K Units) by Company (2015-2020)
Table 75. India Breast Cancer Drugs Sales Market Share by Company (2015-2020)
Table 76. India Breast Cancer Drugs Sales (K Units) by Type (2015-2020)
Table 77. India Breast Cancer Drugs Sales Market Share by Type (2015-2020)
Table 78. India Breast Cancer Drugs Sales (K Units) by Application (2015-2020)
Table 79. India Breast Cancer Drugs Sales Market Share by Application (2015-2020)
Table 80. Roche Group Corporation Information
Table 81. Roche Group Description and Business Overview
Table 82. Roche Group Breast Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Roche Group Breast Cancer Drugs Product
Table 84. Roche Group Recent Development
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Breast Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Novartis Breast Cancer Drugs Product
Table 89. Novartis Recent Development
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Breast Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Pfizer Breast Cancer Drugs Product
Table 94. Pfizer Recent Development
Table 95. Bristol-Myers Squibb Corporation Information
Table 96. Bristol-Myers Squibb Description and Business Overview
Table 97. Bristol-Myers Squibb Breast Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Bristol-Myers Squibb Breast Cancer Drugs Product
Table 99. Bristol-Myers Squibb Recent Development
Table 100. Puma Biotech Corporation Information
Table 101. Puma Biotech Description and Business Overview
Table 102. Puma Biotech Breast Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Puma Biotech Breast Cancer Drugs Product
Table 104. Puma Biotech Recent Development
Table 105. Verzenio (Eli Lilly) Corporation Information
Table 106. Verzenio (Eli Lilly) Description and Business Overview
Table 107. Verzenio (Eli Lilly) Breast Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Verzenio (Eli Lilly) Breast Cancer Drugs Product
Table 109. Verzenio (Eli Lilly) Recent Development
Table 110. HALAVEN (Eisai Inc) Corporation Information
Table 111. HALAVEN (Eisai Inc) Description and Business Overview
Table 112. HALAVEN (Eisai Inc) Breast Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. HALAVEN (Eisai Inc) Breast Cancer Drugs Product
Table 114. HALAVEN (Eisai Inc) Recent Development
Table 115. AstraZeneca Corporation Information
Table 116. AstraZeneca Breast Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. AstraZeneca Description and Business Overview
Table 118. AstraZeneca Breast Cancer Drugs Product
Table 119. AstraZeneca Recent Development
Table 120. GlaxoSmithKline Corporation Information
Table 121. GlaxoSmithKline Breast Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. GlaxoSmithKline Description and Business Overview
Table 123. GlaxoSmithKline Breast Cancer Drugs Product
Table 124. GlaxoSmithKline Recent Development
Table 125. Merck Sharp & Dohme Corp. Corporation Information
Table 126. Merck Sharp & Dohme Corp. Description and Business Overview
Table 127. Merck Sharp & Dohme Corp. Breast Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Merck Sharp & Dohme Corp. Breast Cancer Drugs Product
Table 129. Merck Sharp & Dohme Corp. Recent Development
Table 130. Dr Reddy's Laboratories Corporation Information
Table 131. Dr Reddy's Laboratories Description and Business Overview
Table 132. Dr Reddy's Laboratories Breast Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Dr Reddy's Laboratories Breast Cancer Drugs Product
Table 134. Dr Reddy's Laboratories Recent Development
Table 135. Celltrion Inc Corporation Information
Table 136. Celltrion Inc Description and Business Overview
Table 137. Celltrion Inc Breast Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Celltrion Inc Breast Cancer Drugs Product
Table 139. Celltrion Inc Recent Development
Table 140. Biocon Corporation Information
Table 141. Biocon Description and Business Overview
Table 142. Biocon Breast Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Biocon Breast Cancer Drugs Product
Table 144. Biocon Recent Development
Table . Mylan Corporation Information
Table . Mylan Description and Business Overview
Table . Mylan Breast Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Mylan Breast Cancer Drugs Product
Table . Mylan Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Breast Cancer Drugs Distributors List
Table 153. Breast Cancer Drugs Customers List
Table 154. Market Key Trends
Table 155. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 156. Key Challenges
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Breast Cancer Drugs Product Picture
Figure 2. Global Breast Cancer Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Breast Cancer Drugs Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Clinics Examples
Figure 8. Others Examples
Figure 9. Global Breast Cancer Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Breast Cancer Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Breast Cancer Drugs Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Breast Cancer Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Breast Cancer Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Breast Cancer Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Breast Cancer Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Breast Cancer Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Breast Cancer Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Breast Cancer Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Breast Cancer Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Breast Cancer Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Breast Cancer Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Breast Cancer Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Breast Cancer Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Breast Cancer Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Breast Cancer Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Breast Cancer Drugs Players Market Share by Revenue in Breast Cancer Drugs 2015 & 2019
Figure 27. Breast Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Breast Cancer Drugs Revenue Share by Type (2015-2020)
Figure 29. Global Breast Cancer Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Breast Cancer Drugs Revenue Share by Application (2015-2020)
Figure 31. Global Breast Cancer Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Breast Cancer Drugs Sales Market Share by Type in 2019
Figure 33. United States Breast Cancer Drugs Sales Market Share by Type in 2019
Figure 34. Europe Breast Cancer Drugs Sales Market Share by Company in 2019
Figure 35. Europe Breast Cancer Drugs Sales Market Share by Type in 2019
Figure 36. Europe Breast Cancer Drugs Sales Market Share by Application in 2019
Figure 37. China Breast Cancer Drugs Sales Market Share by Company in 2019
Figure 38. China Breast Cancer Drugs Sales Market Share by Type in 2019
Figure 39. China Breast Cancer Drugs Sales Market Share by Application in 2019
Figure 40. Japan Breast Cancer Drugs Sales Market Share by Company in 2019
Figure 41. Japan Breast Cancer Drugs Sales Market Share by Type in 2019
Figure 42. Japan Breast Cancer Drugs Sales Market Share by Application in 2019
Figure 43. Southeast Asia Breast Cancer Drugs Sales Market Share by Company in 2019
Figure 44. Southeast Asia Breast Cancer Drugs Sales Market Share by Type in 2019
Figure 45. Southeast Asia Breast Cancer Drugs Sales Market Share by Application in 2019
Figure 46. India Breast Cancer Drugs Sales Market Share by Company in 2019
Figure 47. India Breast Cancer Drugs Sales Market Share by Type in 2019
Figure 48. India Breast Cancer Drugs Sales Market Share by Application in 2019
Figure 49. Roche Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Puma Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Verzenio (Eli Lilly) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. HALAVEN (Eisai Inc) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Merck Sharp & Dohme Corp. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Dr Reddy's Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Celltrion Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Key Raw Materials Price Trend
Figure 64. Manufacturing Cost Structure of Breast Cancer Drugs
Figure 65. Manufacturing Process Analysis of Breast Cancer Drugs
Figure 66. Breast Cancer Drugs Industrial Chain Analysis
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Figure 69. Porter's Five Forces Analysis
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
卵巣がん治療薬の世界市場レポート2020 Ovarian cancer is regarded as one of the most common types of cancer among women. It accounts for more deaths than any other cancer of the female reproductive system, while it ranks 5th in overall women deaths due to cancer. This type of cancer is rarely diagnosed at an early stage, making treatment…- 大腸がん治療薬の世界市場レポート2020 A recently published report by QY Research titled Global Colorectal Cancer Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides acc…
- 転移性乳がん治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Metastatic Breast Cancer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metastatic…
- 乳がん画像診断機器の世界市場レポート2020 A variety of devices that provide imaging for breast exams Market Analysis and Insights: Global Breast Cancer Imaging Diagnostic Equipment Market Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization dec…
- 乳がん画像診断装置の世界市場レポート2020 A recently published report by QY Research titled Global Breast Cancer Imaging Diagnostic Equipment Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statist…